Hyperinsulinemia improves ischemic LV function in insulin resistant subjects

Cardiovascular Diabetology

Volumn 9, Issue , 2010, Pages

  Heck, Patrick M ^a   Hoole, Stephen P ^a   Khan, Sadia N ^b   Dutka, David P ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; DOBUTAMINE; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT; C PEPTIDE; FATTY ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE METABOLISM; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; REVASCULARIZATION; STEADY STATE; STRESS ECHOCARDIOGRAPHY; TISSUE DOPPLER IMAGING; VELOCITY; BLOOD; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HEART STROKE VOLUME; HYPERINSULINISM; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; TIME;

AGED; BLOOD GLUCOSE; C-PEPTIDE; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, STRESS; FATTY ACIDS, NONESTERIFIED; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MYOCARDIUM; STROKE VOLUME; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 77954576656     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-27     Document Type: Article

References (52)

1. Young LH, Coven DL, Russell RR. Cellular and molecular regulation of cardiac glucose transport. J Nucl Cardiol 2000, 7:267-276. 10.1016/S1071-3581(00)70016-X, 10888399.
2. Lawson JW, Uyeda K. Effects of insulin and work on fructose 2,6-bisphosphate content and phosphofructokinase activity in perfused rat hearts. J Biol Chem 1987, 262:3165-3173.
3. Hall JL, Henderson J, Hernandez LA, Kellerman LA, Stanley WC. Hyperglycemia results in an increase in myocardial interstitial glucose and glucose uptake during ischemia. Metabolism 1996, 45:542-549. 10.1016/S0026-0495(96)90022-0, 8622595.
4. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr Probl Cardiol 1994, 19:59-113. 10.1016/0146-2806(94)90008-6, 8174388.
5. Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 1981, 23:321-336. 10.1016/0033-0620(81)90019-0, 7012926.
6. Diaz R, Paolasso EA, Piegas LS, Tajer CD, Moreno MG, Corvalan R, Isea JE, Romero G. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 1998, 98:2227-2234.
7. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. Circulation 1997, 96:1152-1156.
8. Malmberg K, Ryden L, Hamsten A, Herlitz J, Waldenstrom A, Wedel H. Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. Eur Heart J 1996, 17:1337-1344.
9. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. Jama 1979, 241:2035-2038. 10.1001/jama.241.19.2035, 430798.
10. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972, 30:595-602. 10.1016/0002-9149(72)90595-4, 4263660.
11. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989, 2:358-367.
12. Madler CF, Paynes N, Wilkenshoff U, Cohen A, Derumeaux GA, Pierard LA, Engvall J, Brodin LA, Sutherland GR, Fraser AG. Non-invasive diagnosis of coronary artery disease by quantitative stress echocardiography: optimal diagnostic models using off-line tissue Doppler in the MYDISE study. Eur Heart J 2003, 24:1584-1594. 10.1016/S0195-668X(03)00099-X, 12927194.
13. Celutkiene J, Sutherland GR, Laucevicius A, Zakarkaite D, Rudys A, Grabauskiene V. Is post-systolic motion the optimal ultrasound parameter to detect induced ischaemia during dobutamine stress echocardiography?. Eur Heart J 2004, 25:932-942. 10.1016/j.ehj.2004.04.005, 15172465.
14. Voigt JU, Lindenmeier G, Exner B, Regenfus M, Werner D, Reulbach U, Nixdorff U, Flachskampf FA, Daniel WG. Incidence and characteristics of segmental postsystolic longitudinal shortening in normal acutely ischemic and scarred myocardium. J Am Soc Echocardiogr 2003, 16:415-423. 10.1016/S0894-7317(03)00111-1, 12724649.
15. Voigt JU, Exner B, Schmiedehausen K, Huchzermeyer C, Reulbach U, Nixdorff U, Platsch G, Kuwert T, Daniel WG, Flachskampf FA. Strain-rate imaging during dobutamine stress echocardiography provides objective evidence of inducible ischemia. Circulation 2003, 107:2120-2126. 10.1161/01.CIR.0000065249.69988.AA, 12682001.
16. Voigt JU, Nixdorff U, Bogdan R, Exner B, Schmiedehausen K, Platsch G, Kuwert T, Daniel WG, Flachskampf FA. Comparison of deformation imaging and velocity imaging for detecting regional inducible ischaemia during dobutamine stress echocardiography. Eur Heart J 2004, 25:1517-1525. 10.1016/j.ehj.2004.05.014, 15342171.
17. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group developed in conjunction with the European Association of Echocardiography a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463. 10.1016/j.echo.2005.10.005, 16376782.
18. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979, 237:E214-223.
19. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages limitations and appropriate usage. Am J Physiol Endocrinol Metab 2008, 294:E15-26. 10.1152/ajpendo.00645.2007, 17957034.
20. Borai A, Livingstone C, Ferns GA. The biochemical assessment of insulin resistance. Ann Clin Biochem 2007, 44:324-342. 10.1258/000456307780945778, 17594780.
21. Turner RC, Holman RR. Pathophysiology of diabetes. Lancet 1976, 2:856. 10.1016/S0140-6736(76)91247-2, 61532.
22. Chiu WC, Kedem J, Scholz PM, Weiss HR. Regional asynchrony of segmental contraction may explain the "oxygen consumption paradox" in stunned myocardium. Basic Res Cardiol 1994, 89:149-162.
23. Fan D, Soei LK, Stubenitsky R, Boersma E, Duncker DJ, Verdouw PD, Krams R. Contribution of asynchrony and nonuniformity to mechanical interaction in normal and stunned myocardium. Am J Physiol Heart Circ Physiol 1997, 273:H2146-2154.
24. Lucats L, Ghaleh B, Monnet X, Colin P, Bize A, Berdeaux A. Conversion of post-systolic wall thickening into ejectional thickening by selective heart rate reduction during myocardial stunning. Eur Heart J 2007, 28:872-879. 10.1093/eurheartj/ehm030, 17376788.
25. Przyklenk K, Patel B, Kloner RA. Diastolic abnormalities of postischemic "stunned" myocardium. Am J Cardiol 1987, 60:1211-1213. 10.1016/0002-9149(87)90435-8, 3687764.
26. Derumeaux G, Ovize M, Loufoua J, Pontier G, Andre-Fouet X, Cribier A. Assessment of nonuniformity of transmural myocardial velocities by color-coded tissue Doppler imaging: characterization of normal ischemic and stunned myocardium. Circulation 2000, 101:1390-1395.
27. Monnet X, Lucats L, Colin P, Derumeaux G, Dubois-Rande J-L, Hittinger L, Ghaleh B, Berdeaux A. Reduction in postsystolic wall thickening during late preconditioning. Am J Physiol Heart Circ Physiol 2007, 292:H158-164. 10.1152/ajpheart.00406.2006, 16920813.
28. Olufadi R, Byrne CD. Clinical and laboratory diagnosis of the metabolic syndrome. J Clin Pathol 2008, 61:697-706. 10.1136/jcp.2007.048363, 18505888.
29. Bing RJ, Siegel A, Ungar I, Gilbert M. Metabolism of the human heart. II. Studies on fat ketone and amino acid metabolism. Am J Med 1954, 16:504-515. 10.1016/0002-9343(54)90365-4, 13148192.
30. Wisneski JA, Gertz EW, Neese RA, Mayr M. Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. J Clin Invest 1987, 79:359-366. 10.1172/JCI112820, 424073, 3805273.
31. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994, 343:155-158. 10.1016/S0140-6736(94)90939-3, 7904009.
32. Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res 1997, 33:243-257. 10.1016/S0008-6363(96)00245-3, 9074687.
33. Barrett EJ, Schwartz RG, Francis CK, Zaret BL. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog. J Clin Invest 1984, 74:1073-1079. 10.1172/JCI111474, 425266, 6381537.
34. Garland PB, Randle PJ. Regulation of glucose uptake by muscles. 10. Effects of alloxan-diabetes, starvation, hypophysectomy and adrenalectomy, and of fatty acids, ketone bodies and pyruvate, on the glycerol output and concentrations of free fatty acids, long-chain fatty acyl-coenzyme A, glycerol phosphate and citrate-cycle intermediates in rat heart and diaphragm muscles. Biochem J 1964, 93:678-687. 1214026, 5839199.
35. Newsholme EA, Randle PJ. Regulation of glucose uptake by muscle. 7. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes, starvation, hypophysectomy and adrenalectomy, on the concentrations of hexose phosphates, nucleotides and inorganic phosphate in perfused rat heart. Biochem J 1964, 93:641-651. 1214023, 4220951.
36. Stanley WC, Lopaschuk GD, McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 1997, 34:25-33. 10.1016/S0008-6363(97)00047-3, 9217869.
37. Saddik M, Lopaschuk GD. Triacylglycerol turnover in isolated working hearts of acutely diabetic rats. Can J Physiol Pharmacol 1994, 72:1110-1119.
38. Wall SR, Lopaschuk GD. Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats. Biochim Biophys Acta 1989, 1006:97-103.
39. Rosano GM, Vitale C, Fragasso G. Metabolic therapy for patients with diabetes mellitus and coronary artery disease. Am J Cardiol 2006, 98:14J-18J. 10.1016/j.amjcard.2006.07.004, 16931201.
40. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 2004, 109:2191-2196. 10.1161/01.CIR.0000127959.28627.F8, 15123530.
41. Abel ED. Myocardial insulin resistance and cardiac complications of diabetes. Curr Drug Targets Immune Endocr Metabol Disord 2005, 5:219-226. 10.2174/1568008054064869, 16089356.
42. Ahmed SS, Jaferi GA, Narang RM, Regan TJ. Preclinical abnormality of left ventricular function in diabetes mellitus. Am Heart J 1975, 89:153-158. 10.1016/0002-8703(75)90039-3, 1114942.
43. Zoneraich S, Silverman G, Zoneraich O. Primary myocardial disease, diabetes mellitus, and small vessel disease. Am Heart J 1980, 100:754-755. 10.1016/0002-8703(80)90243-4, 7446369.
44. Rodrigues B, Cam MC, McNeill JH. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biochem 1998, 180:53-57. 10.1023/A:1006882805197, 9546630.
45. Osorio JC, Stanley WC, Linke A, Castellari M, Diep QN, Panchal AR, Hintze TH, Lopaschuk GD, Recchia FA. Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. Circulation 2002, 106:606-612. 10.1161/01.CIR.0000023531.22727.C1, 12147544.
46. Hall JL, Lopaschuk GD, Barr A, Bringas J, Pizzurro RD, Stanley WC. Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels. Cardiovasc Res 1996, 32:879-885.
47. Iozzo P, Chareonthaitawee P, Dutka D, Betteridge DJ, Ferrannini E, Camici PG. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 2002, 51:3020-3024. 10.2337/diabetes.51.10.3020, 12351442.
48. Dutka DPIP, Pitt M, Chareonthaitawee P, Di Terlizzi M, Ferranini E, et al. Type 2 but not type 1 diabetes is associated with myocardial insulin resistance regardless of the presence of coronary artery disease. J Am Coll Cardiol 2001, 37:300A.
49. Knuuti J, Bengel FM. Positron emission tomography and molecular imaging. Heart 2008, 94:360-367. 10.1136/hrt.2007.118992, 18276820.
50. Kisrieva-Ware Z, Coggan AR, Sharp TL, Dence CS, Gropler RJ, Herrero P. Assessment of myocardial triglyceride oxidation with PET and 11C-palmitate. J Nucl Cardiol 2009, 16:411-421. 10.1007/s12350-009-9051-7, 2854568, 19212800.
51. Gertz EW, Wisneski JA, Stanley WC, Neese RA. Myocardial substrate utilization during exercise in humans. Dual carbon-labeled carbohydrate isotope experiments. J Clin Invest 1988, 82:2017-2025. 10.1172/JCI113822, 442784, 3198763.
52. Monti LD, Landoni C, Setola E, Galluccio E, Lucotti P, Sandoli EP, Origgi A, Lucignani G, Piatti P, Fazio F. Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients. Am J Physiol Heart Circ Physiol 2004, 287:H1225-1231. 10.1152/ajpheart.00629.2003, 15130883.